The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive

By Zimmerman Yvette   Coelingh Bennink Herjan J. T.   Wouters Wout   Ebes Frieda   Fauser Bart C. J. M.  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 6, 2013-12 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone + 30 μg ethinylestradiol to healthy lactating women

By Blode H.   Foidart J.-M.   Heithecker R.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 3, 2001-09 ,pp. : 167-171

Informa Healthcare

Access to resources Recommend Favorite

The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone

By Zimmerman Yvette   Wouters Wout   Coelingh Bennink Herjan J. T.  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 3, 2013-06 ,pp. : 206-214

Informa Healthcare

Access to resources Recommend Favorite

Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms

By Apter D.   Borsos A.   Baumgärtner W.   Melis G.-B.   Vexiau-Robert D.   Colligs-Hakert A.   Palmer M.   Kelly S.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 1, 2003-03 ,pp. : 37-51

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome

By Pehlivanov B.   Mitkov M.  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 1, 2007-01 ,pp. : 30-35

Informa Healthcare

Access to resources Recommend Favorite